語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Radiopharmaceuticals for Therapy
~
SpringerLink (Online service)
Radiopharmaceuticals for Therapy
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Radiopharmaceuticals for Therapy / by F. F. (Russ) Knapp, Ashutosh Dash.
作者:
Knapp, F. F. (Russ).
其他作者:
Dash, Ashutosh.
面頁冊數:
XXIV, 347 p. 157 illus., 85 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Nuclear medicine. -
電子資源:
https://doi.org/10.1007/978-81-322-2607-9
ISBN:
9788132226079
Radiopharmaceuticals for Therapy
Knapp, F. F. (Russ).
Radiopharmaceuticals for Therapy
[electronic resource] /by F. F. (Russ) Knapp, Ashutosh Dash. - 1st ed. 2016. - XXIV, 347 p. 157 illus., 85 illus. in color.online resource.
This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
ISBN: 9788132226079
Standard No.: 10.1007/978-81-322-2607-9doiSubjects--Topical Terms:
673902
Nuclear medicine.
LC Class. No.: R895-920
Dewey Class. No.: 616.07548
Radiopharmaceuticals for Therapy
LDR
:02778nam a22003855i 4500
001
979429
003
DE-He213
005
20200629144507.0
007
cr nn 008mamaa
008
201211s2016 ii | s |||| 0|eng d
020
$a
9788132226079
$9
978-81-322-2607-9
024
7
$a
10.1007/978-81-322-2607-9
$2
doi
035
$a
978-81-322-2607-9
050
4
$a
R895-920
072
7
$a
MMN
$2
bicssc
072
7
$a
MED080000
$2
bisacsh
072
7
$a
MKR
$2
thema
082
0 4
$a
616.07548
$2
23
100
1
$a
Knapp, F. F. (Russ).
$e
author.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
1272515
245
1 0
$a
Radiopharmaceuticals for Therapy
$h
[electronic resource] /
$c
by F. F. (Russ) Knapp, Ashutosh Dash.
250
$a
1st ed. 2016.
264
1
$a
New Delhi :
$b
Springer India :
$b
Imprint: Springer,
$c
2016.
300
$a
XXIV, 347 p. 157 illus., 85 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
520
$a
This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
650
0
$a
Nuclear medicine.
$3
673902
650
0
$a
Pharmacotherapy.
$3
973587
650
0
$a
Oncology .
$3
1253469
650
0
$a
Endocrinology .
$3
1254221
650
1 4
$a
Nuclear Medicine.
$3
673045
650
2 4
$a
Oncology.
$3
593951
650
2 4
$a
Endocrinology.
$3
645497
700
1
$a
Dash, Ashutosh.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
1105544
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9788132226062
776
0 8
$i
Printed edition:
$z
9788132226086
776
0 8
$i
Printed edition:
$z
9788132237983
856
4 0
$u
https://doi.org/10.1007/978-81-322-2607-9
912
$a
ZDB-2-SME
912
$a
ZDB-2-SXM
950
$a
Medicine (SpringerNature-11650)
950
$a
Medicine (R0) (SpringerNature-43714)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入